Undetectable prostate ‐specific antigen after short‐course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis‐free survival and prostate cancer‐specific survival

The Prostate, EarlyView.

Source: The Prostate - July 10, 2018 Category: Urology & Nephrology Authors: Daniel M. LimBS , Roman GulatiMS , Serge Aleshin ‐GuendelBS, BA , Agnes GawneAA , Jonathan T. WingateMD , Heather H. ChengMD, PhD , Ruth EtzioniPhD , Evan Y. YuMD Source Type: research